Last reviewed · How we verify

NCT05452551

Investigation of Myotonometer Reliability in Evaluation of Plantar Fascia Biomechanical Properties

Completed Last updated 7 April 2023
What this trial tests

trial testing Myotonometric measurement in Diabetes in 30 participants. Completed in 1 June 2022.

Timeline
6 July 2021
Primary endpoint
1 March 2022
1 June 2022

Quick facts

Lead sponsorİlke KARA, PT
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date6 July 2021
Primary completion1 March 2022
Estimated completion1 June 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

İlke KARA, PT

Who can join

Adults 18 to 65, any sex, with Diabetes or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to examine the intra-rater, inter-rater, and inter-session reliability of MyotonPRO in measuring plantar fascia mechanical properties in adults with diabetes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Myotonometric measurement

Trials testing the same drug.

Other recruiting trials for Diabetes

Currently open trials in the same condition.

Other İlke KARA, PT trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05452551.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing